Genetic Technologies Partners with CancerIQ to Provide GeneType Risk Assessment Test Portfolio
09/11/24, 12:20 PM
Location
Industry
genetics
health diagnostics
biotechnology
health care
Type
partnership
Genetic Technologies Limited has negotiated a partnership agreement with Chicago-based CancerIQ to provide the GeneType Risk Assessment Test portfolio. This partnership will enable healthcare providers to assess patients' comprehensive risk in order to personalize cancer prevention efforts.
Company Info
Location
melbourne, victoria, australia
Additional Info
Genetic Technologies Limited is a diversified molecular diagnostics company, a global leader in genomics-based tests in health, wellness, and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world.